<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink">
	
	<front>
		<journal-meta>
			<journal-id journal-id-type="nlm-ta">elife</journal-id>
			<journal-id journal-id-type="hwp">eLife</journal-id>
			<journal-id journal-id-type="publisher-id">eLife</journal-id>
			<journal-title-group>
				<journal-title>eLife</journal-title>
			</journal-title-group>
			<issn pub-type="epub">2050-084X</issn>
			<publisher>
				<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">02872</article-id>
			<article-id pub-id-type="doi">10.7554/eLife.02872</article-id>
			<article-categories>
				<subj-group subj-group-type="display-channel">
					<subject>Research Article</subject>
				</subj-group>
				<subj-group subj-group-type="heading">
					<subject>Biochemistry</subject>
				</subj-group>
				<subj-group subj-group-type="heading">
					<subject>Cell Biology</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Cyclin D activates the Rb tumor suppressor by mono-phosphorylation</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author" id="author-12773">
					<name>
						<surname>Narasimha</surname>
						<given-names>Anil M</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Cellular and Molecular Medicine</named-content>
						</addr-line>
						, 
						<institution>University of California, San Diego School of Medicine</institution>
						, 
						<addr-line>
							<named-content content-type="city">La Jolla</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" id="author-12774">
					<name>
						<surname>Kaulich</surname>
						<given-names>Manuel</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Cellular and Molecular Medicine</named-content>
						</addr-line>
						, 
						<institution>University of California, San Diego School of Medicine</institution>
						, 
						<addr-line>
							<named-content content-type="city">La Jolla</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" id="author-12775">
					<name>
						<surname>Shapiro</surname>
						<given-names>Gary S</given-names>
					</name>
					<aff>
						<institution>Sanofi Oncology</institution>
						, 
						<addr-line>
							<named-content content-type="city">Cambridge</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" id="author-12776">
					<name>
						<surname>Choi</surname>
						<given-names>Yoon J</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Genetics</named-content>
						</addr-line>
						, 
						<institution>Harvard Medical School</institution>
						, 
						<addr-line>
							<named-content content-type="city">Boston</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" id="author-4845">
					<name>
						<surname>Sicinski</surname>
						<given-names>Piotr</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Genetics</named-content>
						</addr-line>
						, 
						<institution>Harvard Medical School</institution>
						, 
						<addr-line>
							<named-content content-type="city">Boston</named-content>
						</addr-line>
						, 
						<country>United States</country>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
				<contrib contrib-type="author" corresp="yes" id="author-12441">
					<name>
						<surname>Dowdy</surname>
						<given-names>Steven F</given-names>
					</name>
					<aff>
						<addr-line>
							<named-content content-type="department">Department of Cellular and Molecular Medicine</named-content>
						</addr-line>
						, 
						<institution>University of California, San Diego School of Medicine</institution>
						, 
						<addr-line>
							<named-content content-type="city">La Jolla</named-content>
						</addr-line>
						, 
						<country>United States</country>
						<email>sdowdy@ucsd.edu</email>
					</aff>
					<xref ref-type="fn" rid="conf1"/>
				</contrib>
			</contrib-group>
			<contrib-group content-type="section">
				<contrib contrib-type="editor" id="author-1072">
					<name>
						<surname>Davis</surname>
						<given-names>Roger</given-names>
					</name>
					<role>Reviewing editor</role>
					<aff>
						<institution>University of Massachusetts Medical School</institution>
						, 
						<country>United States</country>
					</aff>
				</contrib>
			</contrib-group>
			<pub-date date-type="pub" publication-format="electronic"><day>29</day><month>05</month><year>2014</year></pub-date><volume>3</volume><elocation-id>e02872</elocation-id>
			<supplementary-material><ext-link xlink:href="elife-02872-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history>
				<date date-type="received">
					<day>23</day>
					<month>03</month>
					<year>2014</year>
				</date>
				<date date-type="accepted">
					<day>22</day>
					<month>05</month>
					<year>2014</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright Â© 2014, Narasimha et al</copyright-statement>
				<copyright-year>2014</copyright-year>
				<copyright-holder>Narasimha et al</copyright-holder>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
					<license-p>
						This article is distributed under the terms of the 
						<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>
						 permitting unrestricted use and redistribution provided that the original author and source are credited.
					</license-p>
				</license>
			</permissions>
			<abstract>
				<p>The widely accepted model of G1 cell cycle progression proposes that cyclin D:Cdk4/6 inactivates the Rb tumor suppressor during early G1 phase by progressive multi-phosphorylation, termed hypo-phosphorylation, to release E2F transcription factors.  However, this model remains unproven biochemically and the biologically active form(s) of Rb remains unknown.  Here we find that Rb is exclusively mono-phosphorylated in early G1 phase by cyclin D:Cdk4/6.  Mono-phosphorylated Rb is composed of 14 independent isoforms that are all targeted by the E1a oncoprotein, but show preferential E2F binding patterns.  At the late G1 Restriction Point, cyclin E:Cdk2 inactivates Rb by quantum hyper-phosphorylation.  Cells undergoing a DNA damage response activate cyclin D:Cdk4/6 to generate mono-phosphorylated Rb that regulates global transcription, whereas cells undergoing differentiation utilize un-phosphorylated Rb.  These observations fundamentally change our understanding of G1 cell cycle progression and show that mono-phosphorylated Rb, generated by cyclin D:Cdk4/6, is the only Rb isoform in early G1 phase.</p>
			</abstract>
			<kwd-group kwd-group-type="research-organism">
				<title>Research organism</title>
				<kwd>Human</kwd></kwd-group>
		</article-meta>
	</front>
	<back>
		<fn-group content-type="competing-interest">
			<title>Competing interest</title>
			<fn fn-type="conflict" id="conf1">
				<p>The authors declare that no competing interests exist.</p>
			</fn>
		</fn-group>
	</back>
</article>